← Back to patent-cliff list
CAS 102193-41-9
17alpha-(Cyanomethyl)-3,3-dimethoxy-13beta-methylgonane-5(10),9(11)-dien-17beta-ol
Codes: (III)90248-5-a
Application context (from source-drug indications)
ContraceptionDienogest/Estradiol ValerateMenorrhagiaDienogest/Estradiol ValerateContraceptive useDienogest/Estradiol ValeratePelvic painDienogest/Estradiol ValerateHeadacheDienogest/Estradiol ValerateDysmenorrhoeaDienogest/Estradiol ValerateContraceptionDienogestEndocrine system disorderDienogestEndometriosisDienogestAdenomyosisDienogestPainDienogest
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Dienogest/Estradiol Valerate | Tier C — Watch / trade | - |
| Dienogest | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3,3-Dimethoxyestra-5(10),9(11)-dien-17-one→Acetonitrile anhydrous→17alpha-(Cyanomethyl)-3,3-dimethoxy-13beta-methylgonane-5(10),9(11)-dien-17beta-ol
3,3-Dimethoxyestra-5(10),9(11)-dien-17-one→Acetonitrile anhydrous→17alpha-(Cyanomethyl)-3,3-dimethoxy-13beta-methylgonane-5(10),9(11)-dien-17beta-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.